Our dynamic team of healthcare education and communication specialists develop engaging educational content and programs for global, regional and single market audiences. We're specialized in translating complex scientific data and shape it in appropriately formats for physicians, nurses, pharmacists, patients and consumers.​ We're uniquely diversity to find the best solution for creating results - from basic editorial concept to publication planning, whatever the task, we produce a strategy and the results that works.

Our experience and relationships with health advocates, thought leaders/KOLs, clinicians, patients and healthcare organizations gives us special insight into every corner of the healthcare marketing, communication, education and advocacy - designed to guide a global conversation about health and healthcare.

We creates a continuing and timely communication and education platform of various publications and media programming designed to inform and inspires the entire healthcare community.


Peter Hofland, Ph.D

Managing Partner & CEO; Executive Editor of ADC Review | Journal of Antibody-drug Conjugates, Onco'Zine and The Onco'Zine Brief

A highly motivated and experienced medical, life sciences and pharma communication and education consultant. He is Managing Partner and CEO of Sunvalley Communication and Managing Partner of InPress Media Group. With a Ph.D in medical science and various postdoctoral training/certificates, Hofland has more than 20 years medical, pharma and life science experience. He is the current Publisher and Executive Editor of the online journal Onco'Zine, The Onco'Zine Brief, a weekly nationally and internationally syndicated radio program about cancer, cancer diagnostics, and treatment, ADC Review | Journal of Antibody-drug Conjugates, a peer reviewed journal focusing on targeted therapies in oncology and hematology, and co-writer and producer of Changing Strategies in the War on Cancer, discussing the current state of cancer treatment.



Shaun Mehr

Vice President | Media Consultant | Sponsorship & Underwriting Development | Print, Online and Broadcast Media Consultant

Over 20 years of leadership experience in partner marketing, B2B marketing, content development, demand generation and integrated marketing. With a solid grasp of both clinical and commercial knowledge, as well as the complex, competitive oncology and hematology marketplace, Mehr specializing in program development for partner, channel and marketing organizations to help in developing compelling strategic communications plans to ensure effective messaging and positioning on global and regional levels. Mehr is the Founder of PCM Results and Vice President | Media Advisor/Consultant at Sunvalley Communication. Mehr is the co-producer of The Onco'Zine Brief and media advisor and underwriting /sponsorship coordinator and advertisement sales manager for ADC Review | Journal of Antibody-drug Conjugates and Onco'Zine.

Eric T. Rosenthal

Eric T. Rosenthal

Independent Medical Journalist | Editor-At-Large of Onco'Zine, The Onco'Zine Brief (on PRX) & Journal of Antibody-drug Conjugates

An independent medical journalist specializing in providing insight, perspective, and transparency into issues, trends, and controversies in oncology, and other areas concerning the politics of health care.

He is currently editor-at-large of ADC Review | Journal of Antibody-drug Conjugates and Onco’Zine, The Onco'Zine Brief, special correspondent for MedPage Today, and a contributor to The Hill. Rosenthal founded EvocaTalk® Research & Reports, a service that identifies, explores, and helps resolve issues, and enhances insights through interactive interviews and analysis.

Formerly a special correspondent for Oncology Times, and senior correspondent and news director for Vital Option International‘s nationally syndicated The Group Room cancer talk-radio show, Rosenthal's reporting is known for its balance providing perspective and context, and taking readers behind the scenes by exploring the “how” and “why,” as evidenced in his series ‘Eric Rosenthal Reports,’ which, in June 2017, returned to Onco’Zine.


Mark Lewis

International Pharma Consultant | Strategic Advisor



With well over 30 years pharmaceutical industry experience - 25 years with companies including Amersham International (now part of GE), Farmitalia (now part of Pfizer), Chiron (now part of Novartis), Groupe Servier, Ascalon and SuperGen (now Otsuka) in various international and headquarter roles and 10 years as a management consultant (Quintiles, Hill & Knowlton) for a spectrum of pharmaceutical, medical device and biotechnology clients. With an honors degree in biochemistry and secondary business qualifications, Lewis has extensive skills in strategic marketing, project management, general management, operations and communications gained in several therapeutic areas, including oncology, respiratory, CNS, cardiology, endocrinology as well as medical and environmental technology. As a strategist, Lewis fully understands the impact that message development has in the future of a pharmaceutical product or compound and helps clients tailor a communications strategy based on needs, goals, and capabilities.

Ready to find out more?

For more information on how we can help you meet your communication goals, please contact Shaun Mehr.